Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network-based stage-specific drug repurposing for Alzheimer's disease. | Comput Struct Biotechnol J | 2022 | 35386099 | PubTator, text mining | PubMed |
| Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies. | J Headache Pain | 2022 | 35382738 | PubTator, text mining | PubMed |
| Development, Pathogenesis, and Regeneration of the Intervertebral Disc: Current and Future Insights Spanning Traditional to Omics Methods. | Front Cell Dev Biol | 2022 | 35359439 | PubTator, text mining | PubMed |
| DNA methylation biomarkers in asthma and rhinitis: Are we there yet? | Clin Transl Allergy | 2022 | 35344303 | PubTator, text mining | PubMed |
| Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System. | Molecules | 2022 | 35335254 | PubTator, text mining | PubMed |
| Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. | Biomolecules | 2022 | 35327609 | PubTator, text mining | PubMed |
| SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets. | Inflammation | 2022 | 35320469 | PubTator, text mining | PubMed |
| International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update. | Pharmacol Rev | 2022 | 35302044 | PubTator, text mining | PubMed |
| Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke. | ACS Med Chem Lett | 2022 | 35295085 | PubTator, text mining | PubMed |
| Identification of Gαi3 as a promising target for osteosarcoma treatment. | Int J Biol Sci | 2022 | 35280670 | PubTator, text mining | PubMed |
| The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications. | Cancers (Basel) | 2022 | 35267424 | PubTator, text mining | PubMed |
| Infections in the Developing Brain: The Role of the Neuro-Immune Axis. | Front Neurol | 2022 | 35250814 | PubTator, text mining | PubMed |
| Potential Role of the Chemotaxis System in Formation and Progression of Intracranial Aneurysms Through Weighted Gene Co-Expression Network Analysis. | Int J Gen Med | 2022 | 35250300 | PubTator, text mining | PubMed |
| Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells. | Int J Mol Sci | 2022 | 35216410 | PubTator, text mining | PubMed |
| A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity. | Pharmaceuticals (Basel) | 2022 | 35215276 | PubTator, text mining | PubMed |
| CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity. | Cell Mol Life Sci | 2022 | 35212809 | PubTator, text mining | PubMed |
| Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity. | Biology (Basel) | 2022 | 35205179 | PubTator, text mining | PubMed |
| Effects of Therapeutic Antibodies on Gene and Protein Signatures in Asthma Patients: A Comparative Systematic Review. | Biomedicines | 2022 | 35203504 | PubTator, text mining | PubMed |
| Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. | Biomedicines | 2022 | 35203484 | PubTator, text mining | PubMed |
| HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models. | Transl Vis Sci Technol | 2022 | 35191964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=18